In 2023, medical supply company Medline sealed nine agreements with health systems, including primary vendor partnerships and a collaboration to co-develop a new supply center in Florida.
As the healthcare supply chain continues to bounce back from COVID-19 disruptions, leaders are monitoring geopolitical concerns, inflation, artificial intelligence and cybersecurity dangers.
More physicians understand the FDA’s approval process for drugs than they do for medical devices, according to findings from a survey published Jan. 16 in Health Affairs.
Medtronic has ended contracts with 200 suppliers, and the medical device company plans to close five manufacturing plants and six distribution centers, according to a Jan. 9 Star Tribune report.
As the FDA investigates China-made plastic syringes because of compatibility issues with syringe pumps, Cardinal Health said 32 million of its syringes are experiencing the same issue.